
Industry
Medical - Devices
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Loading...
Open
5.79
Mkt cap
222M
Volume
3.3M
High
5.81
P/E Ratio
-1.89
52-wk high
14.70
Low
5.77
Div yield
N/A
52-wk low
3.17
Portfolio Pulse from Benzinga Newsdesk
November 02, 2023 | 6:47 pm
Portfolio Pulse from saritha@benzinga.com
November 01, 2023 | 9:00 pm
Portfolio Pulse from Benzinga Insights
October 31, 2023 | 6:01 pm
Portfolio Pulse from Benzinga Newsdesk
September 18, 2023 | 11:09 am
Portfolio Pulse from Benzinga Insights
August 21, 2023 | 7:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 21, 2023 | 11:30 am
Portfolio Pulse from richadhand@benzinga.com
August 17, 2023 | 2:05 pm
Portfolio Pulse from Benzinga Newsdesk
August 16, 2023 | 11:26 am

Portfolio Pulse from Benzinga Insights
August 04, 2023 | 2:11 pm
Portfolio Pulse from richadhand@benzinga.com
August 04, 2023 | 1:47 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.